New research from Beacon Biosignals explores how
Author: Michael
New global report suggests the sector’s next c
HAYA Therapeutics announced that the first cohort
Eisai outlined new and expanded clinical data for
Capsida Biotherapeutics has closed its synrgy Pha
Oligomerix, Inc.
Trinity Capital committed $50 million in growth c
GlycanAge and Circulate Health announced the publ
New Longevity Show blog explores why gyms and he
LW-1017 enters human trials with a new strategy